US Revenue and Competitors
Estimated Revenue & Valuation
- US's estimated annual revenue is currently $14.1M per year.
- US's estimated revenue per employee is $251,000
Employee Data
- US has 56 Employees.
- US grew their employee count by -11% last year.
US's People
| Name | Title | Email/Phone |
|---|
US Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $20.3M | 79 | 20% | N/A | N/A |
#2 | $8.5M | 31 | 11% | N/A | N/A |
#3 | $4.5M | 13 | -13% | N/A | N/A |
#4 | $8M | 25 | -4% | N/A | N/A |
#5 | $5.3M | 16 | -6% | N/A | N/A |
#6 | $54.2M | 163 | -8% | N/A | N/A |
#7 | $12M | 55 | -17% | N/A | N/A |
#8 | $10M | 30 | -9% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 43 | -7% | N/A | N/A |
What Is US?
Astute Medical is committed to improving patient outcomes through the identification and validation of unique biomarkers. Our measurement methods help rapidly assess high-risk acute conditions and diseases. By incoporating useful clinical tools, we help healthcare professionals provide rapid, accurate and life-saving responses.
keywords:N/A
N/A
Total Funding
56
Number of Employees
$14.1M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
US News
WASHINGTON U.S. officials are anxiously watching the French presidential election, aware that the outcome of the vote on Sunday could...
WASHINGTON U.S. officials are anxiously watching the French presidential election, aware that the outcome of the vote on Sunday could...
WASHINGTON U.S. officials are anxiously watching the French presidential election, aware that the outcome of the vote on Sunday could...
WASHINGTON U.S. officials are anxiously watching the French presidential election, aware that the outcome of the vote on Sunday could...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.3M | 56 | -16% | $289.5M |
#2 | $11.5M | 56 | 10% | N/A |
#3 | $5.6M | 56 | 0% | $6.3M |
#4 | $7.3M | 56 | N/A | N/A |
#5 | $7.3M | 56 | N/A | N/A |